Amarin Corporation PLC Stock News

Celltrion Group ha annunciato che l'Agenzia di regolamentazione dei medicinali e dei prodotti sanitari (MHRA) del Regno Unito ha approvato la domanda

Brett Giroir says emphasis should be on "effective" ways to curb the virus despite Trump's continued promotion of hydroxychloroquine.

Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in,...

Federal officials say an outbreak of salmonella infecting nearly 400 people in more than 30 states has been linked to red onions and identified a California company as the likely source

Federal officials say an outbreak of salmonella infecting nearly 400 people in more than 30 states has been linked to red onions and identified a California company as the likely source

Guest lineups for the Sunday news shows

Dr. Anthony Fauci says he is confident that a coronavirus vaccine will be ready by early next year

The White House denied a report claiming the Trump administration scrapped plans for a national coronavirus testing strategy to make Democratic governors in some hard-hit states look bad as "entirely

Right now, too many don't. The former head of immunization at the CDC explains why vaccine hesitancy has become a serious problem.

Making a safe, effective Covid-19 vaccine will be hard enough, but distributing it and building trust for widespread participation will be even harder.

The Food and Drug Administration has not approved hydroxychloroquine for the prevention or treatment of COVID-19. Research has been inconclusive.

Shares of Gilead Sciences Inc. fell more than 1% in after-hours trading Thursday after the drugmaker reported that it swung to a large loss during the second...

Best Chance Products, LLC, a distribution and sales company providing a supply chain of personal protective equipment, has been named the exclusive di

Today, we revisit what has become a 'battleground' stock in the market, Amarin. We update our investment thesis on this name to account for the recent news flow.

If the partisans of America’s elected leadership seem to agree on almost nothing these days, Wednesday’s Big Tech antitrust hearing was stark evidence that they do share one common target.